Open Tender for Revised name and specification of the item: Name: Hyaluronic Acid (Sodium Hyaluronate) for intra-articular visco-supplimentation for knee joint Osteoarthritis Specification: Source Materials:- Non-avian/Non-animal origin, derived by bacterial fermentation. Formulation :- Cross-linked Sodium Hyaluronate gel for prolonged intra-articular residence time and mechanical stability. Molecular weight: High to ultrahigh molecular weight, minimum of 1.5 to 3.0 million Daltons (MDa) to closely replicate healthy human synovial fluid dynamics. Dosage :- Single-Dose Regimen: Must contain a minimum of 20mg/mL to 30 mg/mL of Sodium Hyaluronate, delivering a total dose in a 3.0mL to 6.0 mL volume per pre-filled syringe. Physicochemical Properties:- Clear, colorless, sterile, pyrogen-free, isotonic and buffered solution with physiological pH range between 6.8 and 7.6. Packaging & Delivery Form:- Supplied as read to use, pre- filled syringe manufactured from medical-grade glass or polymer material. Accessories :- Each blister park must include compatible, sterile, disposable hypodermic needles of gauge for kne joint delivery . Quality standards:- Must hold valid FDA approval . Shelf life :- Minimum remaining shelf life of at least 24 months [ ITEM CODE M060508] as per Specn. AI 26-27.